References
- Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010;362:1022–1029.
- Akiyama T, Chikuda H, Yasunaga H, et al. Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database. BMJ Open. 2013;3:1–6.
- Aagaard T, Roed C, Dahl B, et al. Long-term prognosis and causes of death after spondylodiscitis: a Danish nationwide cohort study. Infect Dis (Lond). 2016;48:201–208.
- Murillo O, Grau L, Lora-Tamayo J, et al. The changing epidemiology of bacteaemic osteoarticular infections in the early 21 st century. Clin Microbiol Infect. 2015; 21:254.e1–254.e8.
- Belzunegui J, Intxausti JJ, De Dios JR, et al. Haematogenous vertebral osteomyelitis in the elderly. Clin Rheumatol. 2000;19:344–347.
- Amadoru S, Lim K, Tacey M, et al. Spinal infections in older people: an analysis of demographics, presenting features, microbiology and outcomes. Intern Med J. 2017;47:182–188.
- Courjon J, Lemaignen A, Ghout I, et al. Pyogenic vertebral osteomyelitis of the elderly: characteristics and outcomes. PLoS One. 2017;12:e0188470.
- Dubée V, Lenoir T, Leflon-Guibout V, et al. Three-month antibiotic therapy for early-onset postoperative spinal implant infections. Clin Infect Dis. 2012;55:1481–1487.
- Buzelé R, Zarrouk V, Francoz C, et al. Characteristics of vertebral osteomyelitis after liver transplantation. Clin Microbiol Infect. 2015;21:573–577.
- Bernard L, Dinh A, Ghout I, et al. Duration of Treatment for Spondylodiscitis (DTS) study group. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385:875–882.